Length of stay (LOS), 30-day mortality, and 30-day readmission rates have not been
compared between Medicare beneficiaries with heart failure (HF) with reduced ejection …

Because heart failure (HF) with reduced ejection fraction (HFrEF) and preserved ejection
fraction (HFpEF) are different clinical entities with differing demographic characteristics …

Background It is unknown whether causes and temporal patterns of 30‐day readmission
vary between heart failure (HF) with preserved ejection fraction (HF p EF) and HF with …

Background A prior hospitalization resulting from heart failure is associated with poor
outcomes in ambulatory patients with heart failure. Less is known about this association in …

Context Whether decreases in the length of stay during the past decade for patients with
heart failure (HF) may be associated with changes in outcomes is unknown. Objective To …

Background Follow-up costs among heart failure (HF) patients place a heavy burden on
healthcare. We sought to quantify follow-up costs after a HF hospitalization, as well as …

Hospitals are required to report all-cause 30-day readmissions for patients discharged with
heart failure. Same-cause readmissions have received less attention but may differ for heart …

Background Data on rehospitalizations for heart failure (HF) in Asia are scarce. We sought to
determine the burden and predictors of HF (first and recurrent) rehospitalizations and all …

Despite significant advances in therapies for patients with heart failure with reduced ejection
fraction (HFrEF), there are no evidence-based therapies for heart failure with preserved …

Background Heart failure (HF) is the leading cause of inpatient admissions in the US for
adults aged over 65 years and accounts for more than $17 billion in Medicare expenditures …